WW

WW International, Inc. (WW) Q2 2026 Earnings Call Transcript

WW International NASDAQ: WW, the parent company of Weight Watchers, reported second-quarter 2026 revenue of $162.3 million, down from $189.2 million a year earlier, while highlighting growth in its clinical and higher-value behavioral membership tiers and reaffirming its full-year financial outlook.

Sam's Club Plus members may receive a complimentary three-month Weight Watchers Core membership, while all Sam's Club members can save up to 50% on select Weight Watchers programs

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced a new summer collaboration with FlavCity, the fast-growing health and wellness brand known for bringing transparency, simplicity, and authenticity to everyday food choices. As Weight Watchers' official protein collaborator of the summer, FlavCity will help power the brand's focus on strength, nutrition, and community.

Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the Medicare Bridge Program. Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the Medicare Bridge Program.

Weight Watchers helps members achieve lasting weight loss through medication, personalized nutrition, and community support. As part of its collaboration with the American Heart Association, Weight Watchers is supporting enrollment and engagement in a nationwide study examining real-world health experiences and long-term health outcomes of people living with excess weight across weight management treatment pathways. Weight Watchers helps members achieve lasting weight loss through medication, personalized nutrition, and community support. As part of its collaboration with the American Heart Association, Weight Watchers is supporting enrollment and engagement in a nationwide study examining real-world health experiences and long-term health outcomes of people living with excess weight across weight management treatment pathways.

The collaboration brings clinical and behavioural weight management together, offering UK members a more integrated path to sustainable weight loss.

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) and its affiliated medical groups (“Weight Watchers”), the global leader in science-backed weight management, is now accessible via Eli Lilly and Company's digital healthcare platform, LillyDirect®. This news further reflects Weight Watchers' continued focus on expanding access to trusted, brand-name GLP-1 medications paired with comprehensive clinical and behavioral support, designed for real life.

NEW YORK--(BUSINESS WIRE)--Galloway Capital Partners, LLC (“Galloway”), together with its affiliates, today announced that it has accumulated an ownership stake of approximately 8.42% in WW International, Inc. (“WW” or the “Company”). Galloway believes WW is materially undervalued despite owning one of the world's most recognized wellness brands and operating in the rapidly growing markets of weight management, metabolic health, GLP-1 support, and longevity. Following its recent restructuring,.